[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350902-105":59,"doc-detail-350902-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ripk2-induces-docetaxel-resistance-in-prostate-cancer-through-the-nf-bp-gp-signaling-pathway","RIPK2 induces docetaxel resistance in prostate cancer through the NF-κB/P-gp signaling pathway","","Chemoresistance contributes to treatment failure in prostate cancer. Receptor-interacting protein kinase 2 (RIPK2) is implicated in drug resistance in multiple cancers, but its function and mechanism in prostate-cancer chemoresistance remain unclear. This study analyzes The Cancer Genome Atlas data for RIPK2 expression and clinical correlations, and investigates RIPK2-driven resistance to docetaxel (DTX), highlighting NF-κB activation and P-glycoprotein (P-gp) upregulation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ripk2-induces-docetaxel-resistance-in-prostate-cancer-through-the-nf-bp-gp-signaling-pathway/350902/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ripk2-induces-docetaxel-resistance-in-prostate-cancer-through-the-nf-bp-gp-signaling-pathway/350902.png","ImageObject",300,407,{"name":92,"@type":93},"Finn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study address about prostate cancer treatment failure?","Question",{"text":112,"@type":113},"It examines how docetaxel resistance develops in prostate cancer and whether RIPK2 drives that chemoresistance through specific signaling mechanisms.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is RIPK2 linked to docetaxel (DTX) resistance according to the findings?",{"text":117,"@type":113},"The study reports that RIPK2 is upregulated in prostate-cancer tissues and DTX-resistant cell lines, and mechanistic experiments indicate it promotes resistance by increasing P-gp via NF-κB pathway activation.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence supports the role of RIPK2/P-gp in improving docetaxel efficacy?",{"text":121,"@type":113},"In xenograft tumor experiments, inhibition of RIPK2 or P-gp enhances the effectiveness of docetaxel in suppressing growth of PC-3/DTX tumors.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350902,1790904015,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","OPEN ACCESS  \nCitation: Xing S, Xu Z, Zeng S, Yue M, Xing W, Liu Q (2026) RIPK2 induces docetaxel resistance in prostate cancer through the NF-κB/P-gp signaling pathway. PLoS One 21(1): e0341445. [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pone.0341445  \nEditor: Saki Raheem, University of Westminster  \n-Regent Street Campus: University of Westminster, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND  \nReceived: May 13, 2025  \nAccepted: January 7, 2026  \nPublished: January 21, 2026  \nPeer Review History: PLOS recognizes the benefits of transparency in the peer review process; therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. The editorial history of this article is available here: [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pone.0341445  \nCopyright: © 2026 Xing et al. This is an open access article distributed under the terms of the Creative Commons Attribution License,  \nRESEARCH ARTICLE  \nRIPK2 induces docetaxel resistance in prostate cancer through the NF-κB/P-gp signaling pathway  \nShaoqiang Xing1,2☯, Zhaoliang Xu1,2☯, Sheng Zeng2, Minghao Yue2, Wenzhou Xing2, Qian Liu1,2*  \n1 The First Central Clinical School, Tianjin Medical University, Tianjin, China, 2 Department of Urology, Tianjin First Central Hospital, Tianjin, China  \n☯ These authors contributed equally to this work.  \n* [simonlq1971@126.com](simonlq1971@126.com)  \nAbstract  \nChemoresistance is a reason for treatment failure in prostate cancer. Receptorinteracting protein kinase 2 (RIPK2) has been shown to play a role in drug resistance in various cancers; however, its role and the underlying mechanism of chemoresistance in prostate cancer are unclear. We analyzed data from The Cancer Genome Atlas for RIPK2 expression in prostate cancer and its association with clinicopathological features. We also elucidated the role and mechanism of action of RIPK2 in prostate cancer cell resistance to docetaxel (DTX) . The results showed that RIPK2 expression was upregulated in prostate cancer tissues and was associated with poor pathological grading. RIPK2 was also upregulated in 22RV1/DTX, C4-2/DTX, PC-3/ DTX, and DU145/DTX cell lines and involved in DTX resistance. Mechanistic experiments revealed that RIPK2 was involved in DTX resistance by upregulating Pglycoprotein (P-gp) expression through the activation of the NF-κB signaling pathway. Xenograft tumor experiments confirmed that inhibition of RIPK2 or P-gp enhanced the efficacy of DTX in suppressing PC-3/DTX growth. Taken together, these results suggest that RIPK2 mediates DTX resistance in prostate cancer cells through the NF-κB/P-gp signaling pathway. RIPK2 and its downstream signaling molecules are potential targets for the treatment of chemoresistant prostate cancer.  \nIntroduction  \nProstate cancer is a common genitourinary tumor in men with serious effects on patients’ physical and mental health. Between 2015 and 2022, the incidence of prostate cancer in China increased from 10.2/100,000 to 18.6/100,000 [ 1 ,2] . Currently, treatments for prostate cancer include surgery, endocrine therapy, radiation therapy, chemotherapy, and immunotherapy [3 ,4] . Chemotherapy is an important strategy for the treatment of advanced metastatic prostate cancer following endocrine or  \nPLOS One | [https://doi.org/10.1371/journal.pone.0341445](https://doi.org/10.1371/journal.pone.0341445) January 21, 2026 1 / 14  \nwhich permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData availability statement: All relevant data are within the manuscript and its Supporting  information files.  \nFunding: This work was supported by the Tianjin Key Medical Discipline (Specialty) Construction Project (TJYXZDXK-3-024C) . The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.  \nC","cbCaihX00K60Myxs","https://ap.wps.com/l/cbCaihX00K60Myxs","pdf",1856784,14,"English","# Abstract\n# Introduction\n## Prostate cancer burden and current therapies\n## RIPK2 in inflammation and cancer progression\n## P-glycoprotein and chemoresistance mechanisms","[{\"question\":\"What question does the study address about prostate cancer treatment failure?\",\"answer\":\"It examines how docetaxel resistance develops in prostate cancer and whether RIPK2 drives that chemoresistance through specific signaling mechanisms.\"},{\"question\":\"How is RIPK2 linked to docetaxel (DTX) resistance according to the findings?\",\"answer\":\"The study reports that RIPK2 is upregulated in prostate-cancer tissues and DTX-resistant cell lines, and mechanistic experiments indicate it promotes resistance by increasing P-gp via NF-κB pathway activation.\"},{\"question\":\"What evidence supports the role of RIPK2/P-gp in improving docetaxel efficacy?\",\"answer\":\"In xenograft tumor experiments, inhibition of RIPK2 or P-gp enhances the effectiveness of docetaxel in suppressing growth of PC-3/DTX tumors.\"}]","RIPK2 induces docetaxel resistance in prostate cancer through the NF-κB/P-gp signaling pathway | PDF",1790091726,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ef941052e5a3ecda6589a983cd76c89f.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a3feec307881d7e035a3dc330cfb6d6.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ec7132ff336ed27355182e571cd09646.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c4ffe1edb25dffde3503f2a840b6025.webp",980,1268]